Researchers examining computational & biological approach to flow diversion

Juan Cebral, Professor, Bioengineering, and his collaborators are constructing computational fluid dynamics models of cerebral aneurysms to compare the effects of flow diverters and assess the hemodynamic differences between immediate occlusions and long-term patency. To do so, they are using 3-D rotational angiography images and data on the effects of flow-diverting devices. They will include…

Details

More than 150 awarded in global competition seeking solutions to improve healthy longevity

Oct. 15, 2020 More than 150 Innovators Awarded in Inaugural Round of Global Competition Seeking Solutions to Improve Healthy Longevity More Than $7.7 Million in Prizes Awarded WASHINGTON — The National Academy of Medicine (NAM), together with seven global collaborators representing nearly 50 countries and territories, today announced the winners of the inaugural round of…

Details

Utilizing telemedicine in the ER can reduce wait times and patient length of stay

INFORMS Journal Information Systems Research New Study Key Takeaways: Increasing telemedicine availability in the emergency room (ER) significantly reduces the average patients’ hospital stay. Using telemedicine if there is a demand surge or supply shortage rapidly decreases ER hospital stays. Using telemedicine to reduce a patient’s length of stay is a result of the reduction…

Details

Yang receives funding for services in support of COVID-19 mitigation mapping events

Chaowei Yang, Professor, Director, NSF Spatiotemporal Innovation Center, Geography and Geoinformation Science, received $90,000 from the U.S. Department of State for a project in which researchers at Mason, Harvard, and Colorado State University will address the role of spatiotemporal geospatial data in understanding and mitigating impacts from the global COVID-19 pandemic. The research will focus…

Details

Drug repurposing

University of New Mexico researchers who combed through a “library” of previously approved drugs believe they have identified a medication with the potential to help speed a patient’s recovery from SARS-CoV-2 infection. “The gist of it is we think we found a drug that is on par with remdesivir and is much cheaper,” said Tudor…

Details